WILLIAMS AND JENSEN, PLLC lobbying for BEONE MEDICINES ( FORMERLY KNOWN AS BEIGENE USA, INC.)

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 1

JEANNE HAGGERTY

Previously held: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Health Issues

Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Trade (domestic/foreign)

Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.

Manufacturing

Issues related to drug pricing and reimbursement for prescription drugs related to "Inflation Reduction Act of 2022" (PL 117-169), Subtitle J (Part B and D drug pricing); Issues related to Prescription Drug User Fee Reauthorization. Monitoring activities related to trade. Issues relating to US and international manufacturing.